Heart Rhythm
Volume 6, Issue 5 , Pages 603-604 , May 2009

Searching for triggers of sudden death in hypertrophic cardiomyopathy: Chasing after the wind?

  • J. Vijay Jayachandran, MD, FACC

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. J. Vijay Jayachandran, Fort Worth Heart, 1300 W Rosedale, Fort Worth, Texas 76104

References 

  1. Solomon. Ecclesiastes/Koheleth 8:8. Circa 930 BC.
  2. Maron BJ, Mitten MJ, Quandt EF, et al. Competitive athletes with cardiovascular disease—the case of Nicholas Knapp. N Engl J Med. 1998;339:1632–1635
  3. Willich SN, Levy D, Rocco MB, et al. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol. 1987;60:801–806
  4. Lavery CE, Mittleman MA, Cohen MC, et al. Nonuniform nighttime distribution of acute cardiac events: a possible effect of sleep states. Circulation. 1997;96:3321–3327
  5. Young ME, Razeghi P, Taegtmeyer H. Clock genes in the heart: characterization and attenuation with hypertrophy. Circ Res. 2001;88:1142–1150
  6. Maron BJ, Kogan J, Proschan MA, et al. Circadian variability in the occurrence of sudden cardiac death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1994;23:1405–1409
  7. Kiernan TJ, Weivoda PL, Somers VK, et al. Circadian rhythm of appropriate implantable cardioverter defibrillator discharges in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 2008;31:1253–1258
  8. Maron BJ, Semsarian C, Shen W-K, et al. Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy. Heart Rhythm. 2009;6:599–602
  9. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy (A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines). J Am Coll Cardiol. 2003;42:1687–1713
  10. Maron BJ, Zipes DP. It is not prudent to allow all athletes with implantable-cardioverter defibrillators to participate in all sports. Heart Rhythm. 2008;5:864–866
  11. Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited (A comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities). J Am Coll Cardiol. 2008;52:1990–1996

PII: S1547-5271(09)00295-1

doi: 10.1016/j.hrthm.2009.03.020

Heart Rhythm
Volume 6, Issue 5 , Pages 603-604 , May 2009

Article Tools